For: | Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol 2022; 28(1): 47-75 [PMID: 35125819 DOI: 10.3748/wjg.v28.i1.47] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i1/47.htm |
Number | Citing Articles |
1 |
Ute Gravemann, Michael Engelmann, Volker Kinast, Thomas Burkard, Patrick Behrendt, Torsten J. Schulze, Daniel Todt, Eike Steinmann. Hepatitis E virus is effectively inactivated by methylene blue plus light treatment. Transfusion 2022; 62(11): 2200 doi: 10.1111/trf.17108
|
2 |
Felipe de Jesús Herrera Gómez. Virus de la hepatitis tipo E y su relación con la transfusión sanguínea. Revista Mexicana de Medicina Transfusional 2024; 16(S1): s24 doi: 10.35366/117583
|
3 |
Lin Wang, Youchun Wang, Hui Zhuang. Hepatitis E Virus. Advances in Experimental Medicine and Biology 2023; 1417: 247 doi: 10.1007/978-981-99-1304-6_17
|
4 |
Mahmoud Reza Pourkarim. Hepatitis E Virus; An Underestimated Threat for the Viral Hepatitis Elimination Program. Hepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-129678
|
5 |
Marc Bienz, Christian Renaud, Jia Ru Liu, Philip Wong, Patricia Pelletier. Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening?. Transfusion Medicine Reviews 2024; 38(3): 150835 doi: 10.1016/j.tmrv.2024.150835
|
6 |
Sangthang Singson, Shamee Shastry, N. Sudheesh, Kiran Chawla, Mridula Madiyal, Dhivya Kandasamy, Chiranjay Mukhopadhyay. Assessment of Hepatitis E virus transmission risks: a comprehensive review of cases among blood transfusion recipients and blood donors. Infection Ecology & Epidemiology 2024; 14(1) doi: 10.1080/20008686.2024.2406834
|
7 |
Despoina Papageorgiou, Anne-Lise de Lastic, Olga Tsachouridou, Simeon Metallidis, Karolina Akinosoglou. HEV Infection in Beta-Thalassemia Patients. Pathogens 2024; 13(12): 1058 doi: 10.3390/pathogens13121058
|
8 |
Kanjaksha Ghosh, Prakas Kumar Mandal, Kinjalka Ghosh. Hepatitis E virus as a transfusion transmitted infection-current status. Journal of Hematology and Allied Sciences 2023; 3: 3 doi: 10.25259/JHAS_3_2023
|
9 |
Mohammad Sultan Khuroo. Discovery of Hepatitis E and Its Impact on Global Health: A Journey of 44 Years about an Incredible Human-Interest Story. Viruses 2023; 15(8): 1745 doi: 10.3390/v15081745
|
10 |
Le Chi Cao, Vanessa Martin, Le Thi Kieu Linh, Tran Thi Giang, Ngo Thi Minh Chau, Ton Nu Phuong Anh, Vu Xuan Nghia, Nguyen Trong The, Truong Nhat My, Bui Tien Sy, Nguyen Linh Toan, Le Huu Song, C.-Thomas Bock, Thirumalaisamy P. Velavan. High Hepatitis E Virus (HEV) Seroprevalence and No Evidence of HEV Viraemia in Vietnamese Blood Donors. Viruses 2023; 15(10): 2075 doi: 10.3390/v15102075
|
11 |
Manyu Li, Qiyu He, Tingting Li, Wenjun Wan, Haiwei Zhou. Development and evaluation of a CRISPR-Cas13a system-based diagnostic for hepatitis E virus. Clinical Chemistry and Laboratory Medicine (CCLM) 2024; 62(6): 1237 doi: 10.1515/cclm-2023-1007
|
12 |
Yousif Elnour Elsharif, Bakri Yousif Mohamed Nour, Khidir Osman Alfaki, Samah Abdelrahim Elawad, Ahmed Alsiddiq Ebraheem, Nassir Abakar, Elhadi Abdalla Ahmed. Sero-Detection of HEV in Cancer Patients and Healthcare Workers, Sudan. European Journal of Biomedical Research 2024; 3(2): 1 doi: 10.24018/ejbiomed.2024.3.2.81
|
13 |
Mauro Serricchio, Peter Gowland, Nadja Widmer, Martin Stolz, Christoph Niederhauser. HEV in Blood Donors in Switzerland: The Route to Safe Blood Products. Pathogens 2024; 13(10): 911 doi: 10.3390/pathogens13100911
|
14 |
John P. Pitman, Jean‐Marc Payrat, Min‐Sun Park, Kathy Liu, Laurence Corash, Richard J. Benjamin. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7‐day storage. Transfusion 2023; 63(4): 711 doi: 10.1111/trf.17285
|
15 |
Stefano Fontana, Paolo Ripellino, Christoph Niederhauser, Nadja Widmer, Peter Gowland, Orlando Petrini, Manuela Aprile, Giorgio Merlani, Florian Bihl. Epidemiology of HEV Infection in Blood Donors in Southern Switzerland. Microorganisms 2023; 11(10): 2375 doi: 10.3390/microorganisms11102375
|
16 |
Georges Andreu, Karim Boudjedir, Nicolas Meyer, Monique Carlier, Christian Drouet, Jean-Yves Py, Charles Tacquard, Paul Michel Mertes, Imad Sandid. Platelet Additive Solutions and Pathogen Reduction Impact on Transfusion Safety, Patient Management and Platelet Supply. Transfusion Medicine Reviews 2025; 39(1): 150875 doi: 10.1016/j.tmrv.2025.150875
|
17 |
Amal A. Elkhawaga, Mohamed A. El-Mokhtar, Amal A. Mahmoud, Wael Esmat Ali, Doaa Safwat Mohamed, Ayat M. Kamel, Ahmed Atef Mesalam, Nermien H. S. Mousa, Ahmed M. Ashmawy, Essam M. Abdel Aziz, Ibrahim M. Sayed, Haidi Karam-Allah Ramadan, Yasmine Samy Elkholy. First Report on Abnormal Renal Function in Acute Hepatitis E Genotype 1 Infection. Pathogens 2023; 12(5): 687 doi: 10.3390/pathogens12050687
|
18 |
Edgar D. Copado-Villagrana, Antonio Pizuorno, Adrián García-Suárez, Julio C. Abarca, Gisela DuPont, Socorro Jaramillo-Bueno, Nora A. Fierro. IL-18 discriminates highly frequent hepatitis E virus positive from negative blood donors in Mexico. Annals of Hepatology 2023; 28(5): 101117 doi: 10.1016/j.aohep.2023.101117
|
19 |
Fatemeh Farshadpour, Reza Taherkhani, Marziyeh Shaeri. Prevalence and risk factors of hepatitis E virus infection among patients with β-thalassemia major in South of Iran. Journal of Immunoassay and Immunochemistry 2022; 43(4): 452 doi: 10.1080/15321819.2022.2046602
|
20 |
Jaana Mättö, Niina Putkuri, Ruska Rimhanen-Finne, Päivi Laurila, Jonna Clancy, Jarkko Ihalainen, Susanne Ekblom-Kullberg. Hepatitis E Virus in Finland: Epidemiology and Risk in Blood Donors and in the General Population. Pathogens 2023; 12(3): 484 doi: 10.3390/pathogens12030484
|
21 |
Ricarda Plümers, Jens Dreier, Cornelius Knabbe, Eike Steinmann, Daniel Todt, Tanja Vollmer. Kinetics of Hepatitis E Virus Infections in Asymptomatic Persons. Emerging Infectious Diseases 2024; 30(5) doi: 10.3201/eid3005.231764
|